FDA Approves Radicava (edaravone)
Monday May 8, 2017 — A new drug was approved by the Federal Drug Administration on Friday May 5, 2017 – the first drug to treat ALS approved since 1995. The only other drug on the market today is Riluzole (or, Rilutek, Sanofi-Aventis U.S. LLC) which purports to extend the lives of ALS patients by […]
Read More »